Investment
Features
FeesSafety
Academy
More
Pluang+

Compare YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF (QDTY) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

YieldMax Nasdaq 100 0DTE Covered Call Strategy ETFTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF vs Vir Biotechnology Inc. Common Stock — how do they compare? YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF trades at $37.9 (market cap $29.26M), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Vir Biotechnology Inc. Common Stock is far larger — about 61.5× YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF for 64 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

QDTYVIR
Market Cap
$29.26M$1.80B
Volume
13,5761,782,836
Sector
Income / Options OverlayHealth
52-Week High
$46.71$11.78
52-Week Low
$36.57$5.12
Typical Hold Time
64 Days0 Days
Enterprise Value
—$1.36B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF

QDTY trades at $38.94, down 0.36% with bearish technical signals from moving averages. The ETF maintains a consistent weekly dividend distribution strategy, with recent payments ranging from $0.19 to $0.30 per share. Technical indicators show mixed signals with RSI in neutral territory while ADX suggests weakening trend strength. The stock faces resistance at $40 with support clustered around $39.

The outlook remains cautious given bearish technical momentum and concentrated support levels. Dividend consistency provides income appeal, but technical weakness and tight trading range near current levels suggest limited near-term upside potential. Key risks include market volatility impact on covered call strategies and dependency on Nasdaq 100 performance.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

QDTY

No sentiment data available yet.

VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF

QDTY is an actively managed ETF that employs a synthetic covered call strategy on the Nasdaq-100 Index using zero-days-to-expiration (0DTE) options. It aims to generate high weekly income by selling daily call options, providing limited participation in the index's upside while remaining fully exposed to its downside risk.

Read more on QDTY →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →